The Patent Finder
US

Novel Compound Useful for the Treatement of Degenerative and Inflammatory Diseases

US 9,987,272 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 27, 2032 · High confidence

Filed Jan 25, 2016 as application 15/005,442 · Granted Jun 5, 2018
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Apr 27, 2012
Term ends
Apr 27, 2032
Granted
Jun 5, 2018
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,802,682, to Apr 27, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 27, 2012, when application 13/459,055, the earliest non-provisional in its chain, was filed (this one was filed Jan 25, 2016)Apr 27, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,802,682)resolves to Apr 27, 2032, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 27, 2032High confidence

This family

US 8,802,682In force
Jul 2032
Jul 2032
US 9,241,931In force
Apr 2032
Apr 2032
US 9,987,272this patent
Apr 2032
Apr 2032
Application 15/694,454Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 17, 2017
Reel 43020, frame 673
Menet, Christel Jeanne Marie; Hodges, Alastair James; Vater, Huw David; Biofocus Dpi Ltd.Galapagos N.V.Assignment of Assignor's Interest
Aug 23, 2019
Reel 50149, frame 161
Galapagos N.V.Gilead Sciences, Inc.Security Interest
Jun 4, 2026
Reel 74845, frame 68
GalapagosLakefront BiotherapeuticsChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited